Briacell Therapeutics Corp Capital Reinvestment Ratio
Latest as of October 2012:
116.84x
Briacell Therapeutics Corp capital reinvestment ratio. Briacell Therapeutics Corp (BCTX) has a Capital Reinvestment Ratio of 116.84x as of October 2012, meaning it reinvests 117% of its operating cash flow ($3.96K) in capital expenditures ($462.21K). See cash generation quality of Briacell Therapeutics Corp to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
116.84x
Capex / Operating Cash Flow
Operating Cash Flow
$3.96K
USD
Capital Expenditures
$462.21K
USD
Data as of
Oct 2012
Most recent filing
Briacell Therapeutics Corp Capital Reinvestment Ratio by Year (None–None)
Briacell Therapeutics Corp capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Briacell Therapeutics Corp cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow